PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 211 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $31,000 | -49.2% | 1,300 | -42.7% | 0.01% | -62.5% |
| Q3 2019 | $61,000 | -71.2% | 2,267 | -71.3% | 0.02% | -60.0% |
| Q3 2018 | $212,000 | +27.7% | 7,900 | +132.4% | 0.04% | +5.3% |
| Q4 2017 | $166,000 | -89.3% | 3,400 | -87.7% | 0.04% | -83.3% |
| Q2 2017 | $1,550,000 | +246.8% | 27,590 | +142.0% | 0.23% | +347.1% |
| Q1 2017 | $447,000 | -18.7% | 11,400 | -53.5% | 0.05% | -26.1% |
| Q4 2016 | $550,000 | +135.0% | 24,500 | +147.5% | 0.07% | +115.6% |
| Q2 2016 | $234,000 | -48.8% | 9,900 | -55.8% | 0.03% | -39.6% |
| Q1 2016 | $457,000 | +19.9% | 22,400 | +202.7% | 0.05% | +12.8% |
| Q4 2015 | $381,000 | – | 7,400 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |